H.R. 2009 · 116th Congress

Removing Barriers to Allergy Diagnostic Testing Act of 2019

Stage
In committee
Introduced
2019-04-01
Latest action
2019-04-02 · Referred to the Subcommittee on Health.

Summary

Removing Barriers to Allergy Diagnostic Testing Act of 2019

This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare.

Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.